Bumper Offer - Urjas oil Just @ Rs. 1 X
Zivast F Tablet (10) is a commercial drug that is prescribed in the form of Tablet. The alternative uses of Zivast F Tablet (10) have also been explained below.
The optimal dosage of Zivast F Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
While these are the most often observed Zivast F Tablet (10) side effects, there are can be others also. These have been listed below. Normally, these side effects of Zivast F Tablet (10) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Zivast F Tablet (10)'s effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Zivast F Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zivast F Tablet (10) related warnings section.
Zivast F Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zivast F Tablet (10) in conditions like Allergy, Kidney Disease, Liver Disease.
Besides this, Zivast F Tablet (10) may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Zivast F Tablet (10) is safe while driving, and is addiction.
Zivast F Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Zivast F Tablet (10) is used -
Severe
Is the use of Zivast F Tablet (10) safe for pregnant women?
Zivast F can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Zivast F right away. Take your doctor's advice before taking it again.
Is the use of Zivast F Tablet (10) safe during breastfeeding?
Breastfeeding women may feel side effects of Zivast F. If you see any side effects, stop taking Zivast F immediately and talk to your doctor. Take Zivast F again, only after your doctor's advice.
What is the effect of Zivast F Tablet (10) on the Kidneys?
Zivast F can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Zivast F Tablet (10) on the Liver?
Zivast F is rarely harmful for the liver.
What is the effect of Zivast F Tablet (10) on the Heart?
Information about safety of Zivast F for heart is not available since scientific research on this is yet to be done.
Zivast F Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zivast F Tablet (10) unless your doctor advises you to do so -
Is this Zivast F Tablet (10) habit forming or addictive?
Zivast F Tablet (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Zivast F Tablet (10) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Zivast F Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Zivast F Tablet (10) is not used to treat mental disorders.
Interaction between Food and Zivast F Tablet (10)
Taking Zivast F Tablet (10) with food is safe.
Interaction between Alcohol and Zivast F Tablet (10)
Consuming Zivast F Tablet (10) with alcohol can have many serious effects on your body.
No, use of Zivast F does not cause memory loss in the patients who are taking it. It has not been reported to cause memory loss.
Yes, Zivast F has been reported to cause diarrhea but this occurs in a few cases only. It is the most common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhea after taking this drug, consult your doctor immediately without any further delay.
Yes, Zivast F might cause hair loss but it occurs very rarely. This problem goes away after discontinuation of the drug. However, if you notice excessive hair loss then consult it with your doctor.
Zivast F works by inhibiting an enzyme (HMG-CoA reductase) which is responsible for cholesterol synthesis in our body, its inhibition results in increased levels of HDL (good cholesterol) and decreased levels of LDL (bad cholesterol) which lowers the risk of developing heart disease and helps in preventing strokes
It has been reported to cause weight gain but only in a few cases, this occurs very rarely. However, the exact cause behind this is unknown. if you notice any unusual weight gain after taking this drug. Then you are recommended to discuss it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552